Breaking News Instant updates and real-time market news.

OPNT

Opiant Pharmaceuticals

$15.61

-0.09 (-0.57%)

, EBS

Emergent BioSolutions

$61.56

0.35 (0.57%)

07:25
08/29/18
08/29
07:25
08/29/18
07:25

Cantor sees value in Opiant after Emergent acquires Adapt Pharma

Cantor Fitzgerald analyst Brandon Folkes believes Emergent BioSolutions' (EBS) acquisition of Adapt Pharma underscores the potential for companies addressing the opioid overdose market. Opiant Pharmaceuticals (OPNT) is developing its own opioid overdose nasal spray, OPNT003, which could be of benefit in cases of synthetic opioid overdoses, such as with fentanyl, Folkes tells investors in a research note. He believes Opiant presents an attractive risk/reward at current share levels, "even if it captures only a portion of the growing market opioid overdose market." Folkes keeps an Overweight rating on the shares with a $32 price target.

OPNT

Opiant Pharmaceuticals

$15.61

-0.09 (-0.57%)

EBS

Emergent BioSolutions

$61.56

0.35 (0.57%)

  • 29

    Aug

  • 05

    Sep

  • 05

    Sep

  • 01

    Oct

OPNT Opiant Pharmaceuticals
$15.61

-0.09 (-0.57%)

06/11/18
CANT
06/11/18
INITIATION
Target $32
CANT
Overweight
Opiant Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
Cantor initiated Opiant Pharmaceuticals with an Overweight and $32 price target.
06/12/18
CANT
06/12/18
INITIATION
CANT
Cantor expands Specialty Pharmaceuticals coverage with eight names
Cantor Fitzgerald analyst Brandon Folkes last night rolled out coverage on eight names in the Specialty Pharmaceuticals space. He initiated coverage of AcelRx (ACRX), ANI Pharmaceuticals (ANIP), Biohaven Pharmaceutical (BHVN), Collegium Pharmaceutical (COLL), Emergent BioSolutions (EBS), Eagle Pharmaceuticals (EGRX) and Opiant Pharmaceuticals (OPNT) with Overweight ratings. There is still value to be unlocked in these stocks at current valuations with risk/reward profiles that remain to the upside, Folkes told investors in a research note. His top picks are ANI Pharmaceuticals, Emergent BioSolutions and Collegium Pharmaceutical. The analyst rounded out his coverage with a Neutral rating on Momenta (MNTA), saying the recent share rally puts him on the sidelines "for now."
08/10/18
CANT
08/10/18
NO CHANGE
Target $32
CANT
Overweight
Cantor reiterates Overweight on Opiant ahead of pipeline readouts
Cantor Fitzgerald analyst Brandon Folkes reiterates an Overweight rating on Opiant Pharmaceuticals with a $32 price target following the company's Q2 results. The analyst expect investors to begin to appreciate the market potential of Opiant's pipeline, "which should drive the stock higher." The company is developing treatments focused on multiple addictions as well a new product for opioid overdose, Folkes tells investors in a research note titled "Pipeline Readouts in '18 and '19 Make Us Even More Positive on OPNT Stock."
EBS Emergent BioSolutions
$61.56

0.35 (0.57%)

06/13/18
ARGS
06/13/18
INITIATION
Target $62
ARGS
Buy
Emergent BioSolutions initiated with a Buy at Argus
Argus analyst Mike Jaffe initiated Emergent BioSolutions with a Buy rating and a price target of $62, saying the company is on track to generate "solid earnings growth" in the coming years from the demand of its BioThrax vaccine - the only FDA-approved vaccine for anthrax - from the U.S. military. The analyst also cites added benefits from the company's recently acquired products, its pipeline, and its "strong cost controls". Jaffee further states that the valuation for Emergent BioSolutions at 21.1-times his 2018 EPS estimate is attractive relative to the 26.3-times peer average, adding that the discount is too great based on the company's projected earnings growth rate.
06/13/18
06/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Liberty Global (LBTYA) initiated with a Sell at Berenberg. 2. Emergent BioSolutions (EBS) initiated with a Buy at Argus. 3. Nine Energy Services (NINE) initiated with a Strong Buy at Raymond James. 4. Can-Fite BioPharma (CANF) assumed with a Buy at H.C. Wainwright. 5. Control4 (CTRL) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
WELS
08/10/18
NO CHANGE
Target $61
WELS
Market Perform
Emergent BioSolutions acquisition of PaxVax an 'excellent fit,' says Wells Fargo
After Emergent BioSolutions agreed to acquire PaxVax for $270M, Wells Fargo analyst David Maris said the transaction "sounds as though it is an excellent fit" and he is adding $70M in revenues for 2019 and assuming growth of 10% per year, though he thinks that could be conservative given the possible sales synergies. He also raised his price target on Emergent BioSolutions shares to $61 from $56, though he keeps a Market Perform rating on the shares.
08/29/18
CANT
08/29/18
NO CHANGE
Target $62
CANT
Overweight
Emergent acquisition should bridge guidance gap, says Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes believes Emergent BioSolutions' acquisition of Adapt Pharma and its opioid overdose product, Narcan nasal spray, should help "bridge the Street's gap" from the current 2020 consensus revenue estimate of $830M to the company's guidance of $1B. The analyst keeps an Overweight rating on Emergent with a $62 price target.

TODAY'S FREE FLY STORIES

SLB

Schlumberger

$45.88

0.04 (0.09%)

16:50
04/23/19
04/23
16:50
04/23/19
16:50
Hot Stocks
Schlumberger CFO Simon Ayat sells 0ver $1.1M in company shares »

Schlumberger CFO Simon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 22

    May

  • 13

    Nov

CBS

CBS

$51.35

0.23 (0.45%)

16:49
04/23/19
04/23
16:49
04/23/19
16:49
Hot Stocks
CBS suspends search for new CEO, extends Ianniello as acting CEO »

Joseph Ianniello has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

MVIS

MicroVision

$0.93

-0.02 (-2.11%)

16:49
04/23/19
04/23
16:49
04/23/19
16:49
Syndicate
MicroVision raises $2M in registered direct offering »

MicroVision announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 30

    May

CBS

CBS

$51.35

0.23 (0.45%)

16:47
04/23/19
04/23
16:47
04/23/19
16:47
Periodicals
CBS suspends search for new CEO, Bloomberg says »

CBS said that Joseph…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

FE

FirstEnergy

$40.73

0.14 (0.34%)

16:44
04/23/19
04/23
16:44
04/23/19
16:44
Hot Stocks
Jersey Central Power & Light reaches pact for JCP&L Reliability Plus program »

Jersey Central Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 21

    May

NTRA

Natera

$18.99

0.84 (4.63%)

16:42
04/23/19
04/23
16:42
04/23/19
16:42
Hot Stocks
Integrated Core Strategies reports 5.3% passive stake in Natera »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 28

    May

CRI

Carter's

$105.13

2.02 (1.96%)

16:42
04/23/19
04/23
16:42
04/23/19
16:42
Initiation
Carter's initiated  »

Carter's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

PLCE

Children's Place

$109.92

2.95 (2.76%)

16:41
04/23/19
04/23
16:41
04/23/19
16:41
Initiation
Children's Place initiated  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAC

TransAlta

$6.88

-0.175 (-2.48%)

16:40
04/23/19
04/23
16:40
04/23/19
16:40
Hot Stocks
Mangrove Partners commences action in Ontario court against TransAlta »

Mangrove Partners, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CP

Canadian Pacific

$219.33

0.215 (0.10%)

16:39
04/23/19
04/23
16:39
04/23/19
16:39
Hot Stocks
Breaking Hot Stocks news story on Canadian Pacific »

Canadian Pacific drops 5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 05

    Jun

  • 13

    Nov

LLY

Eli Lilly

$117.51

2.07 (1.79%)

16:39
04/23/19
04/23
16:39
04/23/19
16:39
Upgrade
Eli Lilly rating change  »

Eli Lilly upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

16:38
04/23/19
04/23
16:38
04/23/19
16:38
General news
API crude inventories for week of April 19 »

API reports that crude…

MTH

Meritage Homes

$49.75

1.275 (2.63%)

16:38
04/23/19
04/23
16:38
04/23/19
16:38
Earnings
Meritage Homes sees FY19 EPS $4.65-$4.95, consensus $4.69 »

CEO Steven Hilton said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 17

    May

HZN

Horizon Global

$2.77

0.04 (1.47%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Hot Stocks
Horizon Global board approves amendment to declassify board structure »

Horizon Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BURL

Burlington Stores

$161.96

1.76 (1.10%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Earnings
Burlington Stores narrows Q1 EPS view to $1.21-$1.25 from $1.21-$1.31 »

Q1 consensus $1.29.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TRMK

Trustmark

$34.47

0.7 (2.07%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Earnings
Trustmark reports Q1 EPS 51c, consensus 52c »

Reports Q1 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

PRK

Park National

$95.63

2.2 (2.35%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Hot Stocks
Park National elects CEO Trautman as chairman and EVP Miller as president »

The board of directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

MTH

Meritage Homes

$49.75

1.275 (2.63%)

16:35
04/23/19
04/23
16:35
04/23/19
16:35
Earnings
Meritage Homes reports Q1 EPS 65c, consensus 64c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 17

    May

LRN

K12

$36.23

0.805 (2.27%)

16:35
04/23/19
04/23
16:35
04/23/19
16:35
Earnings
K12 sees FY19 revenue $1.005B-$1.01B, consensus $1.01B »

Sees FY19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

LRN

K12

$36.23

0.805 (2.27%)

16:34
04/23/19
04/23
16:34
04/23/19
16:34
Earnings
K12 reports Q3 EPS 44c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

ROST

Ross Stores

$97.85

0.06 (0.06%)

, BURL

Burlington Stores

$161.96

1.76 (1.10%)

16:34
04/23/19
04/23
16:34
04/23/19
16:34
Hot Stocks
Burlington Stores CEO Thomas Kingsbury to step down, Michael O'Sullivan succeeds »

Burlington Stores (BURL)…

ROST

Ross Stores

$97.85

0.06 (0.06%)

BURL

Burlington Stores

$161.96

1.76 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

NAVI

Navient

$12.45

0.38 (3.15%)

16:33
04/23/19
04/23
16:33
04/23/19
16:33
Earnings
Navient reports Q1 adjusted EPS 58c, consensus 44c »

Reports Q1 revenue $257M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

, BA

Boeing

$374.04

-0.98 (-0.26%)

16:33
04/23/19
04/23
16:33
04/23/19
16:33
Hot Stocks
Kaiser Aluminum says Boeing 737 build rate reduction introduces uncertainty »

"The recent…

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

BA

Boeing

$374.04

-0.98 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 29

    Apr

  • 29

    May

  • 05

    Jun

DORM

Dorman Products

$93.44

0.53 (0.57%)

16:31
04/23/19
04/23
16:31
04/23/19
16:31
Hot Stocks
Dorman Products announces Joseph Braun as SVP and General Counsel »

Dorman Products announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

16:31
04/23/19
04/23
16:31
04/23/19
16:31
Earnings
Kaiser Aluminum reports Q1 adjusted EPS $1.85, consensus $1.79 »

Reports Q1 revenue $395M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.